Clinical Trial Update: Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of AZD1386 in Patients With Osteoarthritis (OA) of the Knee [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating AZD1386 in knee osteoarthritis was terminated, and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• AZD1386 (Capsaicin)

Snippet

Sponsor: AstraZeneca | Conditions: Pain | Phase 2 | Status: TERMINATED | Results posted: 2012-05-28